title: Investigating the link between imipenem resistance and biofilm formation by Pseudomonas aeruginosa.
abstract: Pseudomonas aeruginosa, a ubiquitous environmental organism, is a difficult-to-treat opportunistic pathogen due to its broad-spectrum antibiotic resistance and its ability to form biofilms. In this study, we investigate the link between resistance to a clinically important antibiotic, imipenem, and biofilm formation. First, we observed that the laboratory strain P. aeruginosa PAO1 carrying a mutation in the oprD gene, which confers resistance to imipenem, showed a modest reduction in biofilm formation. We also observed an inverse relationship between imipenem resistance and biofilm formation for imipenem-resistant strains selected in vitro, as well as for clinical isolates. We identified two clinical isolates of P. aeruginosa from the sputum of cystic fibrosis patients that formed robust biofilms, but were sensitive to imipenem (MIC ≤ 2 μg/ml). To test the hypothesis that there is a general link between imipenem resistance and biofilm formation, we performed transposon mutagenesis of these two clinical strains to identify mutants defective in biofilm formation, and then tested these mutants for imipenem resistance. Analysis of the transposon mutants revealed a role for previously described biofilm factors in these clinical isolates of P. aeruginosa, including mutations in the pilY1, pilX, pilW, algC, and pslI genes, but none of the biofilm-deficient mutants became imipenem resistant (MIC ≥ 8 μg/ml), arguing against a general link between biofilm formation and resistance to imipenem. Thus, assessing biofilm formation capabilities of environmental isolates is unlikely to serve as a good predictor of imipenem resistance. We also discuss our findings in light of the limited literature addressing planktonic antibiotic resistance factors that impact biofilm formation.
authors.affiliation: Department of Biology, College of Science, University of Baghdad, Baghdad, Iraq.
authors.forename: Hadeel K
authors.initials: HK
authors.lastname: Musafer
authors.forename: Sherry L
authors.initials: SL
authors.lastname: Kuchma
authors.forename: Amanda A
authors.initials: AA
authors.lastname: Naimie
authors.forename: Joseph D
authors.initials: JD
authors.lastname: Schwartzman
authors.forename: Harith J Fahad
authors.initials: HJ
authors.lastname: Al-Mathkhury
authors.forename: George A
authors.initials: GA
authors.lastname: O'Toole
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D018441:Biofilms; D003550:Cystic Fibrosis / Q000382:microbiology; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D005798:Genes, Bacterial; D006801:Humans; D015378:Imipenem / Q000494:pharmacology*; D009154:Mutation; D018272:Porins / Q000235:genetics* / Q000502:physiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D013183:Sputum / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D018272:Porins; C077157:OprD protein, Pseudomonas aeruginosa; D015378:Imipenem